In our previous studies, we demonstrated that RORγ directly activates AR gene expression and that synthetic RORγ antagonists reduce the expression of AR and its variant AR-V7 and AR-controlled gene programs in PCa cell lines and tumors (Wang et al., 2016; Zhang et al., 2021). This evidence concerns the gene RORC and posterior cortical atrophy.